Toxicity outcomes during 12 months after initiation of TB co-treatment by modification made to the PI-containing regimen.

aToxicity outcomes in children on superboosted LPV/r significantly different to children taking ritonavir only if ≥ grade 1 is selected as the cut-off.当将≥1级作为毒性评估的截断值时，接受超增效洛匹那韦/利托那韦（superboosted LPV/r）治疗的儿童，其毒性结局与仅服用利托那韦的儿童存在显著差异。